Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-026483

VP, Pharmaceutical Development acquired 9,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cappello Joseph · VP, Pharmaceutical Development

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 1 in the form +9,000 9,000 D
Loading xslF345X04/doc4.xml…